Santen Pharmaceutical Co., Ltd. (SNPHY)
10.55
-0.57
(-5.13%)
USD |
OTCM |
Oct 02, 16:00
Santen Pharmaceutical Gross Profit Margin (Quarterly) : 54.66% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 54.66% |
| March 31, 2026 | 61.43% |
| December 31, 2025 | 52.88% |
| September 30, 2025 | 54.69% |
| June 30, 2025 | 50.83% |
| March 31, 2025 | 56.61% |
| December 31, 2024 | 52.51% |
| September 30, 2024 | 53.13% |
| June 30, 2024 | 53.94% |
| March 31, 2024 | 56.98% |
| December 31, 2023 | 55.17% |
| September 30, 2023 | 56.68% |
| June 30, 2023 | 55.31% |
| March 31, 2023 | 62.41% |
| December 31, 2022 | 55.40% |
| September 30, 2022 | 52.50% |
| June 30, 2022 | 52.76% |
| March 31, 2022 | 58.21% |
| December 31, 2021 | 51.81% |
| September 30, 2021 | 55.61% |
| June 30, 2021 | 55.43% |
| March 31, 2021 | 62.80% |
| December 31, 2020 | 54.37% |
| September 30, 2020 | 55.34% |
| June 30, 2020 | 52.77% |
| Date | Value |
|---|---|
| March 31, 2020 | 61.24% |
| December 31, 2019 | 55.10% |
| September 30, 2019 | 55.33% |
| June 30, 2019 | 55.02% |
| March 31, 2019 | 62.67% |
| December 31, 2018 | 56.17% |
| September 30, 2018 | 57.68% |
| June 30, 2018 | 56.16% |
| March 31, 2018 | 61.01% |
| December 31, 2017 | 57.02% |
| September 30, 2017 | 57.94% |
| June 30, 2017 | 58.47% |
| March 31, 2017 | 60.80% |
| December 31, 2016 | 57.63% |
| September 30, 2016 | 61.44% |
| June 30, 2016 | 60.04% |
| March 31, 2016 | 61.56% |
| December 31, 2015 | 57.49% |
| September 30, 2015 | 59.52% |
| June 30, 2015 | 59.77% |
| March 31, 2015 | 66.80% |
| December 31, 2014 | 63.99% |
| September 30, 2014 | 62.77% |
| June 30, 2014 | 59.66% |
| March 31, 2014 | 60.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 57.57% |
| Daiichi Sankyo Co., Ltd. | 78.37% |
| Eisai Co., Ltd. | 78.20% |
| Chugai Pharmaceutical Co., Ltd. | 69.49% |
| Ono Pharmaceutical Co., Ltd. | 75.31% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.52% |
| Return on Assets | 9.49% |
| Return on Invested Capital | 12.06% |
| Profit Margin (Quarterly) | 10.44% |
| Operating Margin (Quarterly) | 11.69% |
| Return on Net Operating Assets | 13.86% |